Key result
Human tissue kallikreins represent a large group of proteases with potential clinical applicability as cancer biomarkers and therapeutic targets.
This review highlights the potential of human tissue kallikreins as cancer biomarkers and therapeutic targets.
Answers are grounded in this paper and cite their sources.
Kallikreins merit evaluation as cancer biomarkers and targets; leaves open their integration into clinical practice.
Human tissue kallikreins (hKs) are attracting increased attention owing to their association with various forms of cancer and other diseases. Human tissue kallikrein genes represent the largest contiguous group of proteases within the human genome. There are many areas of kallikrein research that need to be further explored, including their tissue expression patterns, their regulation, identification of specific substrates, their participation in proteolytic cascades, and their clinical applicability as cancer biomarkers and therapeutic targets. In this review, we briefly describe the current status of kallikrein research and identify future avenues that will enhance our understanding of their function and involvement in human diseases.
No takes yet. Share an insight, caveat, or question.
Paliouras et al. (2006) conducted a review in Cancer and other diseases. Human tissue kallikreins was evaluated. Human tissue kallikreins represent a large group of proteases with potential clinical applicability as cancer biomarkers and therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: